ArticleBMJ (Clinical research ed.)2017

Safety related label changes for new drugs after approval in the US through expedited regulatory pathways: retrospective cohort study.

Sana R Mostaghim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.